文章摘要

参考文献/References

［1］Norgren L, Hiatt WR, Dormandy JA, et al. Intersociety consensus for the management of peripheral arterial disease (TASCⅡ) ［J］. J Vasc Surg, 2007; 45 Suppl S: S5S67.
［2］Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review ［J］. Cardiovasc Intervent Radiol, 2008; 31(4): 687697.
［3］Rückert RI, Tsilimparis N, Lobenstein B, et al. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study ［J］. J Vasc Surg, 2009; 49(5): 12031209.
［4］McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol selfexpanding stent graft vs prosthetic femoralpopliteal bypass in the treatment of superficial femoral artery occlusive disease ［J］. J Vasc Surg, 2009; 49(1): 109116.
［5］Faglia E, Clerici G, Clerissi J, et al. Longterm prognosis of diabetic patients with critical limb ischemia: a populationbased cohort study ［J］. Diabetes Care, 2009; 32(5): 822827.
［6］Graziani L, Silvestro A, Bertone V, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease ［J］. Nephrol Dial Transplant, 2007; 22(4): 11441149.
［7］Chew DK, Conte MS, Donaldson MC, et al. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction ［J］. J Vasc Surg, 2001; 33(2): 259265.
［8］Faries PL, Arota S, Pomposelli FB Jr, et al. The use of arm vein in lowerextremity revascularization: results of 520 procedures performed in eight years ［J］. J Vasc Surg, 2000; 31(1 Pt 1): 5059.
［9］Halloran BG, Lilly MP, Cohn EJ, et al. Tibial bypass using complex autologous conduit: patency and limb salvage ［J］. Ann Vasc Surg, 2001; 15(6): 634643.
［10］Rabellino M, Zander T, Baldi S, et al. Clinical followup in endovascular treatment for TASC CD lesions in femoropopliteal segment ［J］. Catheter Cardiovasc Interv, 2009; 73 (5): 701705.
［11］Donas KP, Schwindt A, Schnefeld T, et al. Belowknee bare nitinol stent placement in highrisk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice ［J］. Eur J Vasc Endovasc Surg, 2009; 37(6): 688693.
［12］Ansel GM, Sample NS, Botti III CF Jr, et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia ［J］. Catheter Cardiovasc Interv, 2004; 61(1): 14.
［13］Engelke C, Sandhu C, Morgan RA, et al. Using 6mm Cutting Balloon angioplasty in patients with resistant peripheral artery stenosis: preliminary results ［J］. AJR Am J Roentgenol, 2002; 179(3): 619623.
［14］Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection ［J］. J Endovasc Ther, 2006; 13(5): 592602.
［15］McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions ［J］. Ann Surg, 2008; 248(4): 519528.
［16］Saxon RR, Coffman JM, Gooding JM, et al. Longterm results of ePTFE stent graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial ［J］. J Vasc Interv Radiol, 2003; 14(3): 303311.
［17］Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent graft ［J］. J Endovasc Ther, 2003; 10(3): 619628.
［18］Farraj N, Srivastava A, Pershad A. Oneyear outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft ［J］. J Invasive Cardiol, 2009; 21(6): 278281.
［19］Deutschmann HA, Schedlbauer P, Bérczi V, et al. Placement of Hemobahn stentgrafts in femoropopliteal arteries: early experience and midterm results in 18 patients ［J］. J Vasc Interv Radiol, 2001; 12(8): 943950.
［20］Duda SH, Poerner TC, Wiesinger B, et al. Drugeluting stents: potential applications for peripheral arterial occlusive disease ［J］. J Vasc Interv Radiol, 2003; 14(3): 291301.
［21］Duda SH, Bosiers M, Lammer J, et al. Sirolimuseluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO Ⅱ trial ［J］. J Vasc Interv Radiol, 2005; 16(3): 331338.
［22］Minar E, Schillinger M. New stents for SFA ［J］. J Cardiovasc Surg (Torino), 2009; 50(5): 635645.
［23］Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting ［J］. Circulation, 2007; 115(21): 27452749.
［24］Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimuseluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6month angiographic results from a nonrandomized prospective singlecenter study ［J］. J Endovasc Ther, 2005; 12(6): 685695.
［25］Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimuseluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1year angiographic and clinical benefit ［J］. J Endovasc Ther, 2007; 14(2): 241250.
［26］Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues ［J］. J Endovasc Ther, 2009; 16 Suppl Ⅰ: Ⅰ153 Ⅰ162.
［27］Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4F selfexpanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia ［J］. J Vasc Interv Radiol, 2007; 18(6): 703708.
［28］王玉琦, 史振宇. 我国血管外科的现状与展望［J］. 中国普外基础与临床杂志, 2008; 15(6): 387389.

我们的网站为什么显示成这样？

下肢动脉闭塞性疾病腔内治疗进展(PDF)

《中国普外基础与临床杂志》[ISSN:1007-9424/CN:51-1505/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics